Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy.
about
Synthesis, antitumor activity, and mechanism of action of 6-acrylic phenethyl ester-2-pyranone derivatives.Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid.Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents deliveryAmphiphilic Cyanine-Platinum Conjugates as Fluorescent Nanodrugs.Self-Assembly of Amphiphilic Drug-Dye Conjugates into Nanoparticles for Imaging and Chemotherapy.Recent updates in utilizing prodrugs in drug delivery (2013-2015).Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo.Immune activity and biodistribution of polypeptide K237 and folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles radiolabeled with 99mTc.Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity.Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery.Sub-100nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy.Nanoprodrug of retinoic acid-modified paclitaxel.A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance.Microfluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents DeliveryA facile supramolecular approach to fabricate multifunctional upconversion nanoparticles as a versatile platform for drug loading, in vivo delivery and tumor imagingDoxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer
P2860
Q35329849-224C2833-FF0A-4053-A9A3-39FFBBFFE3C1Q35574696-DF861B2C-C93E-49CE-AE16-549635FCA561Q35753701-C715CCA9-180E-4F51-963A-103F88E8AF44Q35837874-AE51BDF7-8D72-4581-86B9-08B87BFFA8EFQ36139312-89A2EA8F-9F67-4F5B-B9EA-21F637D0C283Q38702949-8E19B7A1-98CC-40C7-A6A4-507DADCC698CQ38782458-76B8BBAB-35D0-467C-89AC-365966239B09Q38803180-BF06A9A8-B796-4F7C-81DE-EAE5F1F3046CQ40333912-3DD574EA-78F8-40C2-8E81-7594E921197CQ43095122-8CE95718-1662-4070-B25D-AE106C431DF0Q43142557-D37F9CFD-94AC-4CBC-83C9-D339FBDE2F80Q46175023-C1B197E9-C8E4-4169-B1F2-86E94BA0C626Q47811202-5ED3E6F7-BC69-4E2B-AC06-6625ACABC406Q53192470-6470C480-FC3F-4EFA-A7EE-EA6D548E5CCAQ57238661-EFEBD5A2-1DA8-44B1-B259-B6BF9CB62EA9Q57377325-EA705016-6A10-4699-B4BF-B8C656FA7BCFQ59135212-06AD2640-CB43-4D83-8D73-4EA1974ACCDE
P2860
Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Structure-based rational desig ...... r enhanced antitumor efficacy.
@ast
Structure-based rational desig ...... r enhanced antitumor efficacy.
@en
type
label
Structure-based rational desig ...... r enhanced antitumor efficacy.
@ast
Structure-based rational desig ...... r enhanced antitumor efficacy.
@en
prefLabel
Structure-based rational desig ...... r enhanced antitumor efficacy.
@ast
Structure-based rational desig ...... r enhanced antitumor efficacy.
@en
P2093
P2860
P356
P1476
Structure-based rational desig ...... or enhanced antitumor efficacy
@en
P2093
P2860
P304
11532-11537
P356
10.1002/ANIE.201406685
P407
P577
2014-09-04T00:00:00Z